Corcept Therapeutics Incorporated (CORT)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 23.97 |
| Open | 24.17 |
| Bid | 24.43 x 400 |
| Ask | 24.53 x 400 |
| Day's range | 23.61 - 24.62 |
| 52-week range | 20.84 - 34.28 |
| Volume | |
| Avg. volume | 1,106,577 |
| Market cap | 2.549B |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | 23.31 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Corcept Therapeutics First Quarter 2024 Earnings: Beats Expectations
Corcept Therapeutics ( NASDAQ:CORT ) First Quarter 2024 Results Key Financial Results Revenue: US$146.8m (up 39% from...
- Zacks
Corcept (CORT) Q1 Earnings & Revenues Surpass Estimates
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
- Insider Monkey
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
© 2024 Yahoo. All rights reserved.